세계의 바이오소재 시장 : 시장 규모 조사 - 제품별, 용도별, 지역별 예측(2022-2032년)

The Global Biomaterials Market is valued at approximately USD 178.0 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.6% over the forecast period 2024-2032. Biomaterials are substances engineered to interact with biological systems for medical purposes, such as implants, prosthetics, and drug delivery systems. These materials are designed to be compatible with living tissues, promoting healing and regeneration while possessing specific mechanical, chemical, and biological properties. Biomaterials play a pivotal role in various medical applications, facilitating advancements in healthcare and improving patient outcomes. The growing incidence of musculoskeletal and chronic skeletal medical conditions is expected to stimulate the demand for implants based on biomaterials, thereby enhancing market expansion. The increasing prevalence of chronic conditions such as osteoarthritis and degenerative diseases intensifies the demand for advanced biomaterials. Joint replacements and augmentations become essential interventions for individuals facing limited mobility and pain due to these conditions. Metallic biomaterials address this need by offering durable and long-lasting solutions that integrate with the body, restoring functionality and enhancing the quality of life for affected individuals.

Technological advancements continually refine biomaterials, tailoring them to meet specific medical requirements. Innovations focus on improving biocompatibility, corrosion resistance, and the ability to integrate seamlessly with biological systems. This evolution enables the creation of implants that not only withstand the body's biomechanics but also promote healing and integration, reducing the risk of complications post-implantation. In addition, the aging global population contributes significantly to the demand for biomaterials. As the population ages, the prevalence of chronic conditions and age-related injuries rises, amplifying the necessity for effective and durable medical interventions. Biomaterials play a crucial role in addressing these healthcare challenges by offering solutions that align with the unique needs of an aging demographic. Furthermore, the demand for novel biomaterials has been increasing in recent years owing to their growing application in tissue replacement and repair, such as bones, teeth, and other organs.

North America dominated the overall biomaterials market in 2023 due to the initiatives by various public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, offering expertise and support regarding the utilization of biomaterials in biomedical applications. This has led to increased adoption of biomaterials in the region. Additionally, favourable government policies and the concentration of numerous major market players in this area have significantly contributed to the regional market share. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to the strategic initiatives implemented by regional participants to strengthen their position in both local and global markets.

Major market players included in this report are:

• Medtronic
• Evonik Industries AG
• Carpenter Technology Corporation
• Berkeley Advanced Biomaterials
• Invibio Ltd.
• Zimmer Biomet Holdings, Inc.
• BASF SE
• Covalon Technologies Ltd.
• Stryker
• Johnson & Johnson
• Dentsply Sirona
• CoorsTek Inc.
• Corbion
• Regenity Biosciences
• Covalon Technologies Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product:

• Metallic
• Natural
• Ceramics
• Polymers

By Application:

• Cardiovascular
• Ophthalmology
• Dental
• Orthopedic
• Wound Healing
• Tissue Engineering
• Plastic Surgery
• Neurology
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Biomaterials Market Executive Summary

• 1.1. Global Biomaterials Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biomaterials Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Biomaterials Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising incidence of musculoskeletal and chronic skeletal conditions
  • 3.1.2. Technological advancements in biomaterials
  • 3.1.3. Aging global population
• 3.2. Market Challenges
  • 3.2.1. Stringent regulatory approvals
  • 3.2.2. High cost of advanced biomaterials
• 3.3. Market Opportunities
  • 3.3.1. Increased R&D for novel biomaterials
  • 3.3.2. Growing applications in tissue engineering and repair

Chapter 4. Global Biomaterials Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biomaterials Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Biomaterials Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Metallic
  • 5.2.2. Natural
  • 5.2.3. Ceramics
  • 5.2.4. Polymers

Chapter 6. Global Biomaterials Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Biomaterials Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Cardiovascular
  • 6.2.2. Ophthalmology
  • 6.2.3. Dental
  • 6.2.4. Orthopedic
  • 6.2.5. Wound Healing
  • 6.2.6. Tissue Engineering
  • 6.2.7. Plastic Surgery
  • 6.2.8. Neurology
  • 6.2.9. Others

Chapter 7. Global Biomaterials Market Size & Forecasts by Region 2022-2032

• 7.1. North America Biomaterials Market
  • 7.1.1. U.S. Biomaterials Market
    • 7.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Biomaterials Market
• 7.2. Europe Biomaterials Market
  • 7.2.1. U.K. Biomaterials Market
  • 7.2.2. Germany Biomaterials Market
  • 7.2.3. France Biomaterials Market
  • 7.2.4. Spain Biomaterials Market
  • 7.2.5. Italy Biomaterials Market
  • 7.2.6. Rest of Europe Biomaterials Market
• 7.3. Asia-Pacific Biomaterials Market
  • 7.3.1. China Biomaterials Market
  • 7.3.2. India Biomaterials Market
  • 7.3.3. Japan Biomaterials Market
  • 7.3.4. Australia Biomaterials Market
  • 7.3.5. South Korea Biomaterials Market
  • 7.3.6. Rest of Asia Pacific Biomaterials Market
• 7.4. Latin America Biomaterials Market
  • 7.4.1. Brazil Biomaterials Market
  • 7.4.2. Mexico Biomaterials Market
  • 7.4.3. Rest of Latin America Biomaterials Market
• 7.5. Middle East & Africa Biomaterials Market
  • 7.5.1. Saudi Arabia Biomaterials Market
  • 7.5.2. South Africa Biomaterials Market
  • 7.5.3. Rest of Middle East & Africa Biomaterials Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Medtronic
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Evonik Industries AG
  • 8.3.3. Carpenter Technology Corporation
  • 8.3.4. Berkeley Advanced Biomaterials
  • 8.3.5. Invibio Ltd.
  • 8.3.6. Zimmer Biomet Holdings, Inc.
  • 8.3.7. BASF SE
  • 8.3.8. Covalon Technologies Ltd.
  • 8.3.9. Stryker
  • 8.3.10. Johnson & Johnson
  • 8.3.11. Dentsply Sirona
  • 8.3.12. CoorsTek Inc.
  • 8.3.13. Corbion
  • 8.3.14. Regenity Biosciences
  • 8.3.15. Covalon Technologies Ltd.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes